Treatment Indications: correction of deep wrinkles and severe folds (nasolabial folds, marionette lines, deep glabellar and forehead creases);, restoration of significant volume loss in cheeks, cheekbones, temples, and chin;, facial contouring and jawline definition;, non‑surgical rhinoplasty and nasal ridge refinement;, lip augmentation and pronounced volume restoration; structural support and lifting of weakened facial oval
Release form: 2 × 1.1 mL pre‑filled sterile glass syringes
Compound: cross‑linked (stabilized) hyaluronic acid (non‑animal origin, raw material sourced from Shiseido, Japan); lidocaine; BDDE cross‑linking agent; phosphate‑buffered saline solution (pH ~7.0)
Concentration of GC: 24 mg/mL
Lidocaine: 0.3 %
Indications: deep dermal, subdermal, and supraperiosteal injection for restoration of major volume deficits, structural contouring, and deep fold correction;, densest monophasic gel in the Dermalax line utilizing BDDE cross‑linking technology with low‑temperature processing for maximum viscosity, high cohesivity, and stable shape retention;, residual BDDE not detected; providing pronounced lifting effect, even tissue integration, and minimal migration (effect duration ~12–18 months)
.webp)
.webp)
Order via WhatsApp
fillme-sale@ya.ru